Clin2
NCT04979078Possibly a fitRecruiting

Light therapy to ease chemotherapy hand-foot skin reaction

Hand-foot SyndromeHand-foot Skin Reaction

Part of Cancer, Skin clinical trials.

This study tests whether a light-based therapy (photobiomodulation) can reduce pain and skin irritation from hand-foot syndrome/hand-foot skin reaction in people getting chemotherapy or targeted medicines. It may help you heal sooner and feel more comfortable while treatment continues.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have cancer and you’re currently getting chemotherapy or a targeted pill/injection (like a TKI).
  • You already have hand-foot syndrome or hand-foot skin reaction that is mild to moderate (grade 1–3).
  • You can follow the study plan and attend visits.
  • You can sign a consent form to join the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06602167Recruiting
Acupuncture and acupressure to prevent hand-foot syndrome from capecitabine

This trial tests if electroacupuncture combined with self-administered acupressure can prevent hand-foot syndrome, a common side effect of the chemotherapy drug capecitabine. It is for people with gastrointestinal or breast cancer who are starting capecitabine for the first time.

Xining, Qinghai
NCT07681921Not yet recruiting
Light therapy study for nerve pain from cancer treatment

This test uses a light device (photobiomodulation) to see if it can help prevent or reduce nerve damage and pain caused by chemotherapy. It is for patients starting cancer treatment.

Brussels, Brabant
NCT04690439Recruiting
Light therapy to treat breast cancer–related arm swelling

This trial studies whether a noninvasive light-based treatment (photobiomodulation) can reduce breast cancer–related lymphedema, which is swelling in the arm or chest area due to lymph fluid buildup. If you qualify, you’ll be asked to follow a set treatment and follow-up schedule to see if symptoms improve safely.

Hasselt, Limburg
NCT07501442Not yet recruiting
Uracil plaster for hand-foot syndrome from chemotherapy

This trial tests a plaster containing uracil (a natural substance) to treat hand-foot syndrome, a painful skin reaction caused by chemotherapy. It may help reduce redness, swelling, and peeling on your hands and feet.

Rho, MI
NCT07457671Not yet recruiting· Phase 2
TAR-0520 Gel to Prevent Hand-Foot Syndrome

This study tests an investigational gel called TAR-0520 to prevent hand-foot syndrome (pain, redness, peeling) in people starting capecitabine chemotherapy for breast or colorectal cancer. You apply the gel to your hands and feet before and during treatment to see if it helps reduce skin side effects.

Marseille
NCT07375446Not yet recruiting
Chinese medicine foot soak for nerve pain and hand-foot syndrome

This trial tests if a traditional Chinese herbal foot soak can help with nerve pain and hand-foot skin reactions caused by cancer treatments like chemotherapy. It may offer a soothing option for managing these side effects.

Hear when a new Hand-foot Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.